Janet Peper-Gabriel

Janet Peper-Gabriel

Company: Pieris Pharmaceuticals

Job title: Associate Director, Translational Research


Transitioning Inhaled Preclinical Studies to the Clinic: Development of PRS-220, an Inhaled Anticalin Protein targeting CTGF/CCN2 for the Treatment of Lung Fibrosis 10:00 am

Highlighting benefits of local intervention via inhalation versus systemic administration of drugs Using inhaled Anticalin proteins as a novel class of biotherapeutics for respiratory disease Illuminating the development and preclinical characterization of PRS-220, a novel inhaled CTGF inhibitor, that is in clinical development for the treatment of lung fibrosisRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.